American Regent Executive and Leadership Team

Paul Diolosa, the President & Chief Executive Officer at American Regent, directs the overall strategic vision and operational execution for the Daiichi Sankyo Group Company. Diolosa architects the company's growth trajectory, ensuring alignment with market demands for high-quality sterile injectables. Overseeing all business units, the President & Chief Executive Officer drives innovation in manufacturing processes and supply chain management across American Regent's New York, Ohio, and Pennsylvania facilities. This leadership role involves fostering key relationships with healthcare providers, clinics, and hospitals nationwide, solidifying the company's market presence. By championing a culture of excellence, Paul Diolosa ensures the consistent delivery of critical pharmaceutical products that support patient care throughout the United States and Canada.

Joe Boyle, the Vice President, Finance & Chief Financial Officer at American Regent, manages all financial operations and fiscal strategy for the organization. Boyle oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health across the company's multiple locations in New York, Ohio, and Pennsylvania. This executive function includes optimizing financial performance and resource allocation to support the development, manufacturing, and supply of sterile injectables. The Vice President, Finance & Chief Financial Officer also plays a critical part in capital management and investment decisions, aligning financial resources with strategic growth objectives. Through diligent financial oversight, Joe Boyle safeguards the company's assets and drives profitability, enabling American Regent to effectively serve healthcare providers across the United States and Canada.

Ravi Tayi, the Chief Medical Officer at American Regent, provides critical medical and scientific leadership, guiding the company's product development and quality assurance initiatives. Tayi ensures that all manufactured sterile injectables meet the highest standards of safety and efficacy, directly supporting healthcare providers, clinics, and hospitals. This role involves close collaboration with research and development teams to innovate and enhance the product portfolio, addressing evolving medical needs across the United States and Canada. The Chief Medical Officer also oversees clinical compliance and regulatory affairs, ensuring adherence to all relevant healthcare guidelines. By maintaining a sharp focus on patient outcomes, Ravi Tayi reinforces American Regent's commitment to delivering essential pharmaceutical solutions.

Joseph Oestreicher, the Chief People Officer at American Regent, directs all human capital strategies and organizational development initiatives. Oestreicher cultivates a high-performance culture across the company's New York, Ohio, and Pennsylvania sites, focusing on talent acquisition, employee engagement, and professional growth. This executive function is vital for supporting the complex manufacturing and supply chain operations required for sterile injectables. The Chief People Officer ensures that American Regent attracts and retains top talent, fostering an environment where employees can thrive and contribute to the company's mission. By prioritizing workforce development and employee well-being, Joseph Oestreicher strengthens the operational capacity needed to serve healthcare providers nationwide.

Gretchen Fritz, the Vice President, Chief Legal Officer at American Regent, provides comprehensive legal counsel and oversees all corporate governance matters. Fritz manages legal risks and ensures compliance with all applicable laws and regulations across the company's operations in the United States and Canada. This critical role involves advising on contracts, intellectual property, and regulatory affairs pertinent to the development and supply of sterile injectables. The Vice President, Chief Legal Officer also guides the company through complex legal landscapes, protecting American Regent's interests and assets. By ensuring rigorous legal adherence, Gretchen Fritz supports the company's ability to reliably serve healthcare providers and maintain its strong market position.